Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3023)
All Articles published online
|
Aug 7, 2008 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Okan G, Yaylaci S, Peker O, Kaymakoglu S, Saruc M. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol 2008; 14(29): 4697-4700 [PMID: 18698687 DOI: 10.3748/wjg.14.4697] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i29/4697.htm |
| Number | Citing Articles |
| 1 |
Wan-Chen Lin, Tyng-Shiuan Hsieh, Chia-Yu Chu. Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.975754
|
| 2 |
Abimbola Adike, Maxwell L. Smith, Amy Chervenak, Hugo E. Vargas. Hydroxycut-related Vanishing Bile Duct Syndrome. Clinical Gastroenterology and Hepatology 2017; 15(1): 142 doi: 10.1016/j.cgh.2016.04.028
|
| 3 |
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Thomas Harr. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clinical Reviews in Allergy & Immunology 2018; 54(1): 147 doi: 10.1007/s12016-017-8654-z
|
| 4 |
Eran Israeli, Charles N. Bernstein. Yamada' s Textbook of Gastroenterology. 2015; : 2399 doi: 10.1002/9781118512074.ch124
|
| 5 |
Kosuke Sumida, Kazufumi Dohmen, Shinichi Aishima, Sho Iwasaka, Satomi Hisamoto, Yukiko Harada, Noriko Miyake, Nobuyuki Shimono, Shinji Shimoda. A case of vanishing bile duct syndrome complicated with toxic epidermal necrolysis performed liver biopsy three times subsequently. Kanzo 2013; 54(1): 67 doi: 10.2957/kanzo.54.67
|
| 6 |
Manuela G. Neuman, Lawrence B. Cohen, Radu M. Nanau. Quinolones-induced hypersensitivity reactions. Clinical Biochemistry 2015; 48(10-11): 716 doi: 10.1016/j.clinbiochem.2015.04.006
|
| 7 |
Naomi Gronich, David Maman, Nili Stein, Walid Saliba. Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study. American Journal of Clinical Dermatology 2022; 23(2): 257 doi: 10.1007/s40257-021-00661-0
|
| 8 |
Ananth Kashyap, Sahana Sreenivasan, Asha K Rajan, Muhammed Rashid, Manik Chhabra. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(3): 327 doi: 10.1515/jbcpp-2020-0115
|
| 9 |
Jianglin Wang, Shengfeng Wang, Cuifang Wu, Zhenzhen Deng. Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis. Infection 2024; 52(3): 891 doi: 10.1007/s15010-023-02132-6
|
| 10 |
J. A. Jaffey. Canine intrahepatic biliary disease. Journal of Small Animal Practice 2022; 63(3): 167 doi: 10.1111/jsap.13433
|
| 11 |
Juricic Danica, Hrstic Irena, Radic Davor, Skegro Mate, Coric Marijana, Vucelic Boris, Francetic Igor. Vanishing Bile Duct Syndrome Associated with Azithromycin in a 62‐Year‐Old Man. Basic & Clinical Pharmacology & Toxicology 2010; 106(1): 62 doi: 10.1111/j.1742-7843.2009.00474.x
|
| 12 |
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis. ACG Case Reports Journal 2018; 5(12): e951 doi: 10.14309/02075970-201805120-00011
|
| 13 |
Paul Wasuwanich, Hassan Choudry, Joshua M. So, Sarah Lowry, Wikrom Karnsakul. Vanishing bile duct syndrome after drug-induced liver injury. Clinics and Research in Hepatology and Gastroenterology 2022; 46(9): 102015 doi: 10.1016/j.clinre.2022.102015
|
| 14 |
Manmeet S. Padda, Mayra Sanchez, Abbasi J. Akhtar, James L. Boyer. Drug-induced cholestasis. Hepatology 2011; 53(4): 1377 doi: 10.1002/hep.24229
|
| 15 |
Anna Licata, Claudia Randazzo, Ilaria Morreale, Giuseppe Butera, Natale D’Alessandro, Antonio Craxì. Fluoroquinolone-induced liver injury: three new cases and a review of the literature. European Journal of Clinical Pharmacology 2012; 68(5): 525 doi: 10.1007/s00228-011-1201-6
|
| 16 |
Hye-young Kim, Hea Kyoung Yang, Seong Heon Kim, Jae Hong Park. Ibuprofen Associated Acute Vanishing Bile Duct Syndrome and Toxic Epidermal Necrolysis in an Infant. Yonsei Medical Journal 2014; 55(3): 834 doi: 10.3349/ymj.2014.55.3.834
|
| 17 |
Jason C. White, Stephanie Appleman. Infliximab/Plasmapheresis in Vanishing Bile Duct Syndrome Secondary to Toxic Epidermal Necrolysis. Pediatrics 2014; 134(4): e1194 doi: 10.1542/peds.2013-2239
|
| 18 |
Marianne Lerch, Thomas Harr. Cutaneous Drug Hypersensitivity. 2022; : 29 doi: 10.1007/978-3-030-82743-4_4
|
| 19 |
Fumitaka Mizuno, Norihiro Imai, Kazushi Yasuda, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis. Internal Medicine 2024; 63(1): 57 doi: 10.2169/internalmedicine.1826-23
|
| 20 |
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis. ACG Case Reports Journal 2018; 5(1): e95 doi: 10.14309/02075970-201805000-00095
|
| 21 |
Jianglin Wang, Cuifang Wu, Zhenzhen Deng. Nonsteroidal anti-inflammatory drugs-associated vanishing bile duct syndrome: a real-world retrospective and disproportionality analysis. Expert Opinion on Drug Safety 2024; : 1 doi: 10.1080/14740338.2024.2416537
|
| 22 |
Thomas H. Tung. Tacrolimus (FK506): Safety and Applications in Reconstructive Surgery. HAND 2010; 5(1): 1 doi: 10.1007/s11552-009-9193-8
|
| 23 |
Kento Shionoya, Masahiro Kobayashi, Makoto Kako, Sakue Masuda, Makomo Makazu, Kazuya Koizumi. Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome. Internal Medicine 2024; 63(12): 1719 doi: 10.2169/internalmedicine.2427-23
|
| 24 |
Sahand Rahnama-Moghadam, Hans L. Tillmann. DILI Associated with Skin Reactions. Current Hepatology Reports 2018; 17(3): 225 doi: 10.1007/s11901-018-0414-x
|
| 25 |
Xi Chen, Cheng Zhang, Hua Wang, Juan Xu, Zi-Hao Duan, Ying Zhang, Tao Yu, Wei Wei, De-Xiang Xu, Jian-Ming Xu. Altered integrity and decreased expression of hepatocyte tight junctions in rifampicin-induced cholestasis in mice. Toxicology and Applied Pharmacology 2009; 240(1): 26 doi: 10.1016/j.taap.2009.06.022
|
| 26 |
Current World Literature. Current Opinion in Pediatrics 2009; 21(4): 553 doi: 10.1097/MOP.0b013e3283300b10
|
| 27 |
Michael J Eiswerth, Matthew A Heckroth, Ali Ismail, Dibson D Gondim, Ryan Kaufman. Infliximab-Induced Vanishing Bile Duct Syndrome. Cureus 2022; doi: 10.7759/cureus.21940
|
| 28 |
H.Y. Lee, S.A. Walsh, D. Creamer. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up. British Journal of Dermatology 2017; 177(4): 924 doi: 10.1111/bjd.15360
|
| 29 |
Fernando Bessone, Nelia Hernández, Mario Tanno, Marcelo G. Roma. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics. Seminars in Liver Disease 2021; 41(03): 331 doi: 10.1055/s-0041-1729972
|
| 30 |
Jose M. Pinazo-Bandera, Juan Pedro Toro-Ortiz, Raúl J. Andrade, Miren García-Cortés. Drug-induced cholestasis: causative agents and challenges in diagnosis and management. Exploration of Digestive Diseases 2023; 2(5): 202 doi: 10.37349/edd.2023.00027
|
| 31 |
Soraya Salas-Silva, Arturo Simoni-Nieves, Jocelyn Lopez-Ramirez, Leticia Bucio, Luis E. Gómez-Quiroz, María Concepción Gutiérrez-Ruiz, Marcelo G. Roma. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies. Life Sciences 2019; 218: 324 doi: 10.1016/j.lfs.2018.12.044
|
| 32 |
Ahmed Hashim, Ashley Barnabas, Rosa Miquel, Kosh Agarwal. Successful liver transplantation for drug-induced vanishing bile duct syndrome. BMJ Case Reports 2020; 13(1): e233052 doi: 10.1136/bcr-2019-233052
|
| 33 |
Kyrillos Faragalla, Helena Lau, Hanlin L. Wang, Jimin Liu. Cloxacillin‐induced acute vanishing bile duct syndrome: A case study and literature review. British Journal of Clinical Pharmacology 2022; 88(10): 4633 doi: 10.1111/bcp.15445
|